ClinicalTrials.Veeva

Menu

High Dose and Low Dose of Atorvastatin in Patients With Unstable Angina and NSTEMI (Non ST Elevation MI)

H

Hormozgan University of Medical Sciences

Status

Completed

Conditions

Cardiovascular Disease

Treatments

Drug: Low dose Atorvastatin
Drug: High dose atorvastatin

Study type

Interventional

Funder types

Other

Identifiers

NCT01306565
Atorvastatin and CRP level

Details and patient eligibility

About

The aim of this study is to compare the effect of high dose and low dose of Atorvastatin in reduction level of C-reactive protein (CRP) in patients with unstable angina and NSTEMI (Non ST Elevation MI) attending Shahid Mohammadi hospital in Bandar Abbas.

Full description

This study compare the effect of 80mg atorvastatin followed by two 20mg daily atorvastatin with three 80mg daily atorvastatin in reduction of CRP in patients with unstable angina and NSTEMI (Non ST Elevation MI) attending Shahid Mohammadi hospital in Bandar Abbas in 2009.

Enrollment

100 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with unstable angina with chest discomfort at rest with normal EKG or St depression (at least 0.1mv) in two consecutive leads or new and deep T inversion (at least 0.2mv)

Exclusion criteria

  • Myocardial Infarction with ST elevation
  • Diabetes Mellitus
  • Previous statin use
  • Current infectious disease

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

100 participants in 2 patient groups

High dose atorvastatin
Active Comparator group
Description:
Three 80mg daily doses of atorvastatin
Treatment:
Drug: Low dose Atorvastatin
Low dose Atorvastatin
Experimental group
Description:
80mg atorvastatin followed by two 20mg daily atorvastatin
Treatment:
Drug: High dose atorvastatin

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems